Literature DB >> 9931668

[Plastic reconstruction of the irradiated thoracic wall].

P M Vogt1, K Busch, F W Peter, C Möcklinghoff, A Torres, H U Steinau.   

Abstract

Chest-wall reconstruction following irradiation requires a surgical approach that addresses the specific healing disorders associated with irradiation: (1) biopsy of any open wound to rule out recurrence or persistence of tumor; (2) aggressive debridement of all necrotic or infected tissue, especially osteonecrosis of the chest wall; (3) reconstruction with well-vascularized muscle or musculocutaneous flaps. Coverage with muscle flaps provides a very reliable and effective single-stage reconstruction. Most types of flaps employed involve the latissimus, rectus abdominis and pectoralis muscle or musculocutaneous flaps. Rarely, stabilization of the thoracic wall is required, mostly facilitated by nonresorbable mesh. Respecting these principles, the irradiated chest wall can be reconstructed safely and with low morbidity. Plastic reconstructive techniques may also be employed safely to reconstruct the breast simultaneously in irradiated tissue by use of latissimus or rectus abdominis flaps.

Entities:  

Mesh:

Year:  1998        PMID: 9931668

Source DB:  PubMed          Journal:  Langenbecks Arch Chir Suppl Kongressbd        ISSN: 0942-2854


  3 in total

1.  Reconstruction of the thoracic wall-long-term follow-up including pulmonary function tests.

Authors:  Adrien Daigeler; Daniel Druecke; Mitra Hakimi; Hans-Werner Duchna; Ole Goertz; Heinz-Herbert Homann; Marcus Lehnhardt; Hans-Ulrich Steinau
Journal:  Langenbecks Arch Surg       Date:  2008-08-02       Impact factor: 3.445

2.  Thoracic Wall Reconstruction in Advanced Breast Tumours.

Authors:  A Daigeler; K Harati; O Goertz; T Hirsch; B Behr; M Lehnhardt; J Kolbenschlag
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-06       Impact factor: 2.915

Review 3.  Thoracic Wall Reconstruction after Tumor Resection.

Authors:  Kamran Harati; Jonas Kolbenschlag; Björn Behr; Ole Goertz; Tobias Hirsch; Nicolai Kapalschinski; Andrej Ring; Marcus Lehnhardt; Adrien Daigeler
Journal:  Front Oncol       Date:  2015-10-29       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.